August 9, 2026

Newsletter

The European Post

Policy • Diplomacy • Strategic Insight

LATEST
New EU Gas Market Rules Take Effect With Consumer SafeguardsDeforestation Regulation Holds Its December Deadline Despite CutsDigital Omnibus Delays Europe’s High-Risk AI Deadline to 2027Europe’s Schools Confront a Widening Basic Skills GapRule of Law Report Finds Progress but Trust Still LagsIRIS2 Gains 66 Satellites as Brussels Signs the Rollout DealNature Restoration Plans Come Due as Member States Race a DeadlineECB Rates Hold at 2.25 Percent as Frankfurt Waits on the DataEU Budget Talks Turn to Cohesion as Ireland Takes OverWildfire Response Stretches Europe’s Emergency Fleet ThinCan Europe’s Quantum Plan Match Its Big Ambitions?Armenia Edges West as Moscow’s Grip Slips AwayEurope Inherits the World’s Aid Bill It Cannot Fully PayAir Passenger Rights Get Their First Overhaul in Two DecadesErasmus Opens a 5 Billion Euro Round for Skills and MobilityCeuta Crisis Pushes the EU Toward Faster Migrant ReturnsBulky Parcels Face a Packaging Crackdown From August 12Can Europe Build Its Drone Wall Before 2030 Arrives?Indonesia’s Trade Deal With Europe Nears Its Final SignatureEurope Leans on Beijing to Keep Climate Talks Alive Before AntalyaNew EU Gas Market Rules Take Effect With Consumer SafeguardsDeforestation Regulation Holds Its December Deadline Despite CutsDigital Omnibus Delays Europe’s High-Risk AI Deadline to 2027Europe’s Schools Confront a Widening Basic Skills GapRule of Law Report Finds Progress but Trust Still LagsIRIS2 Gains 66 Satellites as Brussels Signs the Rollout DealNature Restoration Plans Come Due as Member States Race a DeadlineECB Rates Hold at 2.25 Percent as Frankfurt Waits on the DataEU Budget Talks Turn to Cohesion as Ireland Takes OverWildfire Response Stretches Europe’s Emergency Fleet ThinCan Europe’s Quantum Plan Match Its Big Ambitions?Armenia Edges West as Moscow’s Grip Slips AwayEurope Inherits the World’s Aid Bill It Cannot Fully PayAir Passenger Rights Get Their First Overhaul in Two DecadesErasmus Opens a 5 Billion Euro Round for Skills and MobilityCeuta Crisis Pushes the EU Toward Faster Migrant ReturnsBulky Parcels Face a Packaging Crackdown From August 12Can Europe Build Its Drone Wall Before 2030 Arrives?Indonesia’s Trade Deal With Europe Nears Its Final SignatureEurope Leans on Beijing to Keep Climate Talks Alive Before Antalya
August 9, 2026

Newsletter

The European Post

Policy • Diplomacy • Strategic Insight

LATEST
New EU Gas Market Rules Take Effect With Consumer SafeguardsDeforestation Regulation Holds Its December Deadline Despite CutsDigital Omnibus Delays Europe’s High-Risk AI Deadline to 2027Europe’s Schools Confront a Widening Basic Skills GapRule of Law Report Finds Progress but Trust Still LagsIRIS2 Gains 66 Satellites as Brussels Signs the Rollout DealNature Restoration Plans Come Due as Member States Race a DeadlineECB Rates Hold at 2.25 Percent as Frankfurt Waits on the DataEU Budget Talks Turn to Cohesion as Ireland Takes OverWildfire Response Stretches Europe’s Emergency Fleet ThinCan Europe’s Quantum Plan Match Its Big Ambitions?Armenia Edges West as Moscow’s Grip Slips AwayEurope Inherits the World’s Aid Bill It Cannot Fully PayAir Passenger Rights Get Their First Overhaul in Two DecadesErasmus Opens a 5 Billion Euro Round for Skills and MobilityCeuta Crisis Pushes the EU Toward Faster Migrant ReturnsBulky Parcels Face a Packaging Crackdown From August 12Can Europe Build Its Drone Wall Before 2030 Arrives?Indonesia’s Trade Deal With Europe Nears Its Final SignatureEurope Leans on Beijing to Keep Climate Talks Alive Before AntalyaNew EU Gas Market Rules Take Effect With Consumer SafeguardsDeforestation Regulation Holds Its December Deadline Despite CutsDigital Omnibus Delays Europe’s High-Risk AI Deadline to 2027Europe’s Schools Confront a Widening Basic Skills GapRule of Law Report Finds Progress but Trust Still LagsIRIS2 Gains 66 Satellites as Brussels Signs the Rollout DealNature Restoration Plans Come Due as Member States Race a DeadlineECB Rates Hold at 2.25 Percent as Frankfurt Waits on the DataEU Budget Talks Turn to Cohesion as Ireland Takes OverWildfire Response Stretches Europe’s Emergency Fleet ThinCan Europe’s Quantum Plan Match Its Big Ambitions?Armenia Edges West as Moscow’s Grip Slips AwayEurope Inherits the World’s Aid Bill It Cannot Fully PayAir Passenger Rights Get Their First Overhaul in Two DecadesErasmus Opens a 5 Billion Euro Round for Skills and MobilityCeuta Crisis Pushes the EU Toward Faster Migrant ReturnsBulky Parcels Face a Packaging Crackdown From August 12Can Europe Build Its Drone Wall Before 2030 Arrives?Indonesia’s Trade Deal With Europe Nears Its Final SignatureEurope Leans on Beijing to Keep Climate Talks Alive Before Antalya

Strategic Projects Anchor The Critical Medicines Act Provisional Deal

Rudolf Nureyev
Parliament Reporter, Health and Wellbeing

Strasbourg: The provisional deal on the Critical Medicines Act struck on 12 May closes a file that had bounced between capitals, Parliament committees, and the rotating Council presidency for over a year. Co-legislators landed on a text that combines public procurement reforms with new investment vehicles for European manufacturing capacity, after intensive trilogue work that ran into the spring.

The provisional agreement now waits for formal endorsement at both Council and Parliament level, with legal-linguistic revision the only remaining technical step. Rapporteurs have flagged early autumn as a realistic adoption window. Stakeholders in pharmacy associations, generic medicine manufacturers, and patient organisations all signalled cautious approval, while raising concerns about the pace at which Strategic Projects can deliver visible relief on the shortages front.

Antibiotics, insulin, and painkillers headline the list of medicines that have driven the political urgency behind the file. Shortages of these classes have repeatedly tested national health systems, particularly during winter peaks, and several capitals had pressed for stronger tools to coordinate procurement and signal supply risks earlier. The agreed text introduces explicit obligations on Member States to incentivise resilience when running tenders for critical medicines, including diversification of supply sources and consideration of European manufacturing capacity.

The Strategic Projects framework sits at the heart of the resilience pillar. Manufacturers that propose to boost, modernise, or build new capacity for critical medicines or their active substances in the EU will gain access to fast-tracked permitting and prioritised funding routes. Both Union and Member State funding can flow through the Strategic Project channel, and administrative support is built into the design to shrink time-to-decision. Officials inside DG SANTE see the framework as the legislative counterpart to industrial policy moves already underway through the European Investment Bank and national development banks.

Joint procurement becomes easier under the deal. Member States that choose to pool demand for critical medicines will operate through a clearer legal frame, designed to simplify coordination and reduce the risk of one capital outbidding another during a supply squeeze. The voluntary character of joint procurement remains, but the legal scaffolding gets a meaningful upgrade.

Generic and biosimilar producers were a key constituency in the negotiation. Their margins on older medicines are thin, and the file recognises that pure price competition has hollowed out European manufacturing of some active substances to a small number of global suppliers, often concentrated outside the bloc. The compromise text includes provisions designed to recognise European supply resilience as a procurement criterion, alongside price, in tenders for critical medicines. The wording does not mandate a fixed weighting, leaving Member States flexibility, but it builds a clearer legal basis than existed before.

Patient organisations welcomed the deal but warned that implementation timelines matter. Strategic Projects can take years to deliver visible capacity gains, and the shortage problem is acute now. The compromise reflects that tension by combining short-term tools, including early notification obligations and stockpiling provisions, with longer-term capacity instruments. Whether the balance is right will only become clear once the regulation enters into force and national agencies begin operating the new tools.

External voices flagged the international angle. Some commentators have warned that the European focus on supply resilience could complicate generic medicine flows to lower-income countries that depend on European-manufactured generics, particularly in parts of Africa. The Commission has insisted that the regulation is not protectionist and that diversification, rather than reshoring as such, is the policy intent. The next phase of debate will likely focus on how the Strategic Projects framework is operationalised and whether the procurement criteria are calibrated to reward genuine resilience rather than narrowly defined European preference.

Comments